Genome Research Limited (GRL) is a private-limited-guaranteed Scottish Charity, operating as a research and experimental development entity focused on biotechnology. Established in 1992, GRL is a wholly-owned subsidiary of the Wellcome Trust, a global charitable organization dedicated to advancing health and well-being. GRL’s core business centers around the investigation and development of novel genomic technologies and applications. The company’s primary services encompass genomic sequencing, data analysis, and the creation of bespoke research tools and solutions for pharmaceutical, diagnostic, and agricultural industries. They specialize in utilizing advanced sequencing techniques to identify and characterize genetic variations, contributing to advancements in personalized medicine and crop improvement. The Wellcome Genome Campus, a collaborative research facility, provides a supportive environment for GRL’s activities. GRL’s international presence is facilitated through collaborations and partnerships with research institutions worldwide. The company’s size is estimated to be a relatively small, focused organization dedicated to impactful research. GRL’s hiring indicators suggest a commitment to scientific expertise and collaboration. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology.

Genome Research Limited (GRL) is a private-limited-guaranteed Scottish Charity, operating as a research and experimental development entity focused on biotechnology. Established in 1992, GRL is a wholly-owned subsidiary of the Wellcome Trust, a global charitable organization dedicated to advancing health and well-being. GRL’s core business centers around the investigation and development of novel genomic technologies and applications. The company’s primary services encompass genomic sequencing, data analysis, and the creation of bespoke research tools and solutions for pharmaceutical, diagnostic, and agricultural industries. They specialize in utilizing advanced sequencing techniques to identify and characterize genetic variations, contributing to advancements in personalized medicine and crop improvement. The Wellcome Genome Campus, a collaborative research facility, provides a supportive environment for GRL’s activities. GRL’s international presence is facilitated through collaborations and partnerships with research institutions worldwide. The company’s size is estimated to be a relatively small, focused organization dedicated to impactful research. GRL’s hiring indicators suggest a commitment to scientific expertise and collaboration. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology.